drugs for neglected diseases initiative

Removing Early Barriers To Drugs For Neglected Diseases

DNDi has formed a consortium with four pharmaceutical companies to hasten the development of drugs for leishmaniasis and Chagas disease.

US$12 Million In Grants Awarded For Neglected Diseases

Japan's Global Health Initiative Technology Fund has committed US$12 million in grants for neglected diseases and a potential tuberculosis vaccine.

Japan Launches Public-Private Partnership To Fight Neglected Diseases

The Global Health Innovative Technology Fund, a new public-private partnership, is taking Japanese R&D to the global fight against infectious disease.

WHO Prequalifies Indian Malaria Drug

A new artemisinin-based malaria drug produced by Indian pharmaceutical company Cipla has been prequalified by the World Health Organization (WHO).

Coalition Aims To Eradicate 10 Neglected Tropical Diseases By 2020

A large coalition of pharmas, governments, and NGOs have announced their goal of eliminating or controlling 10 neglected tropical diseases by 2020.

Sanofi And DNDi To Tackle Nine Neglected Tropical Diseases

Sanofi and the Drugs for Neglected Diseases initiative will develop new treatments for nine neglected tropical diseases listed by the World Health Organization.